SF3B1 mutations are relatively uncommon in chronic myelomonocytic leukemia (CMML) patients, occurring in about 5–6% of cases, and similar to MDS, these mutations are associated with the RS phenotype [25,28,29]. This evidence concerns the gene SF3B1 and myelodysplastic syndrome.